BREAST CANCER
Max Planck Institute for Molecular Biomedicine
Münster, AlemaniaPublications in collaboration with researchers from Max Planck Institute for Molecular Biomedicine (1)
2021
-
Discovery and proof-of-concept study of nuclease activity as a novel biomarker for breast cancer tumors
Cancers, Vol. 13, Núm. 2, pp. 1-16